drugset / Trial / NCT04926259
Tau PET Imaging With 18F-T807(AV1451) in Neurodegenerative Disorders
NaSingle-groupOpen-labelDiagnostic
Summary
Alzheimer's disease, Parkinson's disease, and Huntington's disease are common neurodegenerative diseases. Tau is a microtubule-associated protein, and aggregated tau resulting from hyperphosphorylation is a pathological feature of a group of neurodegenerative diseases known as tauopathies. The 18F-T807 (AV1451) molecular probe is a novel molecularly targeted imaging agent that exhibits high affinity and good selectivity for tau.
Timeline
- Start
- 2021-11-01
- Primary completion
- 2024-12-01
- Completion
- 2024-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | florbetapir F 18 | Diagnostic / imaging agent | 370 mbq | Intravenous |